[go: up one dir, main page]

MX2021011550A - Formulaciones de pregabalina y uso de las mismas. - Google Patents

Formulaciones de pregabalina y uso de las mismas.

Info

Publication number
MX2021011550A
MX2021011550A MX2021011550A MX2021011550A MX2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A MX 2021011550 A MX2021011550 A MX 2021011550A
Authority
MX
Mexico
Prior art keywords
pregabalin
animals
composition
formulations
pregabalin formulations
Prior art date
Application number
MX2021011550A
Other languages
English (en)
Inventor
Mirja Huhtinen
Terttu Lamminen
Jukka Salmia
Johanna Tervapuro
Jurgen Vercruysse
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of MX2021011550A publication Critical patent/MX2021011550A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a una composición farmacéutica en forma de una composición líquida de administración oral que comprende pregabalina como principio activo y al uso de la misma en el tratamiento y la prevención de la ansiedad y el miedo al transporte y a la visita veterinaria en animales de compañía, como los gatos. La composición es estable, bien palatable para los animales y puede ser administrada fácilmente por el propietario de la mascota.
MX2021011550A 2019-03-26 2020-03-26 Formulaciones de pregabalina y uso de las mismas. MX2021011550A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20195226 2019-03-26
PCT/FI2020/050193 WO2020193864A1 (en) 2019-03-26 2020-03-26 Pregabalin formulations and use thereof

Publications (1)

Publication Number Publication Date
MX2021011550A true MX2021011550A (es) 2021-10-26

Family

ID=70292991

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011550A MX2021011550A (es) 2019-03-26 2020-03-26 Formulaciones de pregabalina y uso de las mismas.

Country Status (9)

Country Link
US (1) US20220175707A1 (es)
EP (1) EP3946260A1 (es)
JP (1) JP7500600B2 (es)
KR (1) KR20210143874A (es)
CN (1) CN113631150A (es)
AU (1) AU2020249679B2 (es)
CA (1) CA3131336A1 (es)
MX (1) MX2021011550A (es)
WO (1) WO2020193864A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116172951A (zh) * 2023-03-08 2023-05-30 杭州润宠归美生物科技有限公司 一种宠物用普瑞巴林药物组合物及其制备方法和应用
CN120585747A (zh) * 2025-06-17 2025-09-05 北京诺和动保科技有限公司 普瑞巴林内服溶液及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
NZ529173A (en) * 2001-05-25 2005-07-29 Warner Lambert Co Stable liquid pharmaceutical composition comprising a GABA analog i.e. gabapentin or pregabalin, and a polyhydric alcohol e.g. glycerol, xylitol, sorbitol, mannitol
EP1543831A1 (en) 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
EP2240158A2 (en) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin

Also Published As

Publication number Publication date
JP2022528520A (ja) 2022-06-14
CN113631150A (zh) 2021-11-09
JP7500600B2 (ja) 2024-06-17
WO2020193864A1 (en) 2020-10-01
AU2020249679A1 (en) 2021-11-18
KR20210143874A (ko) 2021-11-29
CA3131336A1 (en) 2020-10-01
EP3946260A1 (en) 2022-02-09
AU2020249679B2 (en) 2024-11-21
US20220175707A1 (en) 2022-06-09

Similar Documents

Publication Publication Date Title
GT201000160A (es) Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales
PL410258A1 (pl) Weterynaryjne doustne kompozycje przeciwpasożytnicze obejmujące działające systemowo substancje czynne, sposoby i zastosowania je obejmujące
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
CL2017002936A1 (es) Compuestos ciclooctadepsipéptidos, composición veterinaria antihelmíntica, y uso para preparar un medicamento útil contra infección por parásitos o una infestación por parásitos internos o externos en un animal.
AR123902A2 (es) Composición veterinaria oral para el control de inapetencia para un gato o un perro
MX2021011550A (es) Formulaciones de pregabalina y uso de las mismas.
AR054987A1 (es) Composicion veterinaria trasmucosal
ECSP19044591A (es) Amidas aromáticas de ácido carboxílico como antagonistas del receptor b1 de la bradiquinina
MX2016014256A (es) Formulaciones y metodos para el suministro vaginal de antiprogestinas.
ECSP099734A (es) Composición farmaceutica que comprende la combinación de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
CR20160021A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
CL2009000987A1 (es) Composición de alimentación que comprende peptidoglicano y nucleotidos; y su uso para la profilaxis y/o tratamiento de enfermedades infecciosas en animales.
AR103555A1 (es) Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso
AR074674A1 (es) Combinacion de sustancias activas mejorada que comprende un antibiotico y un farmaco antiinflamatorio no esteroideo (aine)
MX2023010847A (es) Formulaciones de tasipimidina y uso de las mismas.
AR072889A1 (es) Combinacion coccidicida para uso veterinario
BR112016007057A2 (pt) um método veterinário para induzir êmese
MX2014013083A (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
Parmar et al. Therapeutic management of canine demodicosis
Hagawane et al. Ethno-veterinary drug therapy for ear mange in sheep
MX2016006375A (es) Una combinacion de unidades de dosificacion para su uso en el tratamiento del parto prematuro.
AR067561A1 (es) Medicamento para la aplicacion transdermica en animales
ES2328327A1 (es) Fase amorfa de una pirazolina sustituida, su preparacion y su uso comomedicamento.
BR112020019160A8 (pt) Formulação
CL2008002899A1 (es) Composicion farmaceutica veterinaria que comprende 4"-deoxi-4"epimetilamino avermectina b1a/b1b como ingrediente activo; procedimiento para preparar dicha composicion; uso de la composicion para tratar o prevenir enfermedades parasitarias en salmones y truchas.